Earnings Feed
Start Free
Home/Filings/4/0001213900-22-062481
4//SEC Filing

Mazur Leonard L 4

Accession 0001213900-22-062481

CIK 0001506251other
View on SEC.govCompany Profile

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 4:08 PM ET

Size

26.4 KB

Accession

0001213900-22-062481

Insider Transaction Report

Form 4
Period: 2022-10-04
Citius Pharmaceuticals, Inc.CTXR
Mazur Leonard L
DirectorChief Executive Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2022-10-04+550,000→ 550,000 total
    Exercise: $1.25Exp: 2032-10-04→ Common Stock (550,000 underlying)
Holdings

  • Options to Purchase Common Stock

    Exercise: $6.75Exp: 2024-09-12→ Common Stock (220,000 underlying)
    220,000

  • Warrant to Purchase Common Stock

    Exercise: $2.86Exp: 2023-09-29→ Common Stock (167,504 underlying)
    167,504

  • Warrant to Purchase Common Stock

    Exercise: $0.77Exp: 2024-09-27→ Common Stock (2,234,700 underlying)
    2,234,700

  • Options to Purchase Common Stock

    Exercise: $0.67Exp: 2029-10-08→ Common Stock (175,000 underlying)
    175,000

  • Options to Purchase Common Stock

    Exercise: $2.00Exp: 2031-07-22→ Common Stock (300,000 underlying)
    300,000

  • Warrant to Purchase Common Stock

    Exercise: $1.42Exp: 2024-04-05→ Common Stock (1,165,048 underlying)
    1,615,048

  • Common Stock

    10,255,343

  • Options to Purchase Common Stock

    Exercise: $3.45Exp: 2027-09-13→ Common Stock (40,000 underlying)
    40,000

  • Warrant to Purchase Common Stock

    Exercise: $4.13Exp: 2022-08-08→ Common Stock (421,400 underlying)
    421,400

  • Warrant to Purchase Common Stock

    Exercise: $4.13Exp: 2022-08-08→ Common Stock (11,000 underlying)
    11,000

  • Warrant to Purchase Common Stock

    Exercise: $4.63Exp: 2023-06-19→ Common Stock (106,553 underlying)
    106,553

  • Warrant to Purchase Common Stock

    Exercise: $1.15Exp: 2023-08-14→ Common Stock (3,137,255 underlying)
    3,137,255

  • Options to Purchase Common Stock

    Exercise: $1.62Exp: 2028-09-04→ Common Stock (150,000 underlying)
    150,000

  • Options to Purchase Common Stock

    Exercise: $1.01Exp: 2030-10-06→ Common Stock (200,000 underlying)
    200,000

  • Option to Purchase Common Stock

    Exercise: $2.04Exp: 2031-10-11→ Common Stock (650,000 underlying)
    650,000
Footnotes (9)
  • [F1]One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest, provided the Reporting Person continues to serve as a member of the Company's Board of Directors as of each such vesting date.
  • [F2]The warrant is fully vested and exercisable immediately.
  • [F3]The option vested as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017.
  • [F4]One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.
  • [F5]The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
  • [F6]The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
  • [F7]The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
  • [F8]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
  • [F9]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Documents

1 file

Issuer

Citius Pharmaceuticals, Inc.

CIK 0001506251

→
Entity typeother

Related Parties

1
  • filerCIK 0001463414

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:08 PM ET
Size
26.4 KB
View on SEC.gov